secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-08-23T23:59:59+00:00
Accession:  0001104659-24-092491
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics receives Nasdaq non-compliance notice for late Form 10-Q filing
--------------------------------------------------------------------------------

- Nasdaq notice on Aug 21, 2024, for failure to timely file Q2 2024 Form 10-Q.
- Company has 60 days (until Oct 21, 2024) to submit compliance plan; possible extension to Feb 17, 2025.
- Forvis Mazars resigned as auditor on Aug 9, 2024; company seeking new independent accounting firm.
- Notice has no immediate effect on Nasdaq listing, but delisting risk if compliance not regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924092491/0001104659-24-092491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924092491/tm2422567d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-092491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer